The impact of the genetic component to your sensitivities to medications is elaborated in our Comprehensive Pharmacogenomics Report: a clinically-validated test designed to examine potential risk of side effects, dosing guidance, and drug metabolism. As one of the first phamacogenomic tests to examine the relationship between your clinical variants and prescription drugs using Illumina’s Global Screening Array, the report provides insights on the unique clinical consequences of your genetic makeup, and offers a list of alternatives to potentially impacted medications.
The Pharmacogenomics Report provides a convenient summary card that highlights the critical genes responsible for drug response and metabolism, which are invaluable to both patients and healthcare providers. The report will help improve quality care by enabling precision medicine and promoting proactive approaches to prescription drugs.
Drug classes tested:
Requires physician’s approval and patient’s consent. Please consult with your healthcare provider for more information.